Company intelligence / Profile preview
Rongchang Pharmaceuticals
Yantai, Shandong, Chinarongchang.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Rongchang Pharmaceuticals is a leading Chinese pharmaceutical conglomerate with a focus on modern traditional Chinese medicine, small molecule drugs, biologics—including mAbs and ADCs—and contract manufacturing. Its subsidiary RemeGen has achieved commercial approval for telitacicept for SLE in China and disitamab vedotin for gastric cancer. The group maintains a robust late-stage clinical pipeline targeting oncology, autoimmune diseases, and ophthalmology.
- Therapeutic areas
- OncologyOphthalmologyImmunology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Fusion proteinsBispecific antibodies
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Not explicitly listed but likely includes global licensing/commercialization partners through its subsidiary programs.
Beyond the preview
Go deeper on Rongchang Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rongchang Pharmaceuticals.